Bacterial membrane-modified cerium oxide nanoboosters enhance systemic antitumor effects of radiotherapy in metastatic triple-negative breast cancer
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Radiotherapy plays an important role in the treatment of triple-negative breast cancer, yet its ability to trigger systemic responses against distant tumors remains limited. To address this challenge, we developed a biomimetic nanobooster by incorporating cerium oxide (CeO2) nanoparticles with bacterial outer membrane vesicles (OMVs), termed CeO2@OMV. This innovative strategy overcomes the limitations of conventional radiotherapy by enhancing antigen release and improving immune cell infiltration, thereby amplifying its effectiveness in combating both primary and metastatic tumors. The biocompatibility, antitumor effects, bystander and immunomodulatory impacts of the nanoboosters were assessed by comprehensive in vitro assays and in vivo breast cancer models. Our results demonstrated that CeO2@OMVs can selectively inhibit cancer cells while protecting normal tissue upon irradiation. Additionally, the nanoboosters induced immunogenic cell death, enhanced macrophage polarization, and suppressed the growth of bystander tumors. In vivo studies demonstrated that CeO2@OMVs, when combined with radiotherapy, significantly improved local tumor control and triggered systemic immune responses, leading to substantial inhibition of both primary and distant tumors, effectively preventing new metastases. In conclusion, our CeO2@OMV nanoboosters offer a promising therapeutic strategy against metastatic breast cancer, providing a novel tool to achieve radiation-induced abscopal effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies also reported systemic effects, including responses in non-irradiated tumor sites [17,22,36].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Inhibition of metastatic progression and systemic tumor control were also reported in selected studies [22,43,45].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Triple-negative breast cancer models, particularly 4T1 and MDA-MB-231, predominated throughout the literature [15,16,17,20,21,22,23,39,40,45,52,55,56,68,69,74,76,77,81], whereas luminal and HER2-positive subtypes were comparatively underrepresented [24,29,35,51,62].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 54 · Cited by 11
Metadata
- Authors
- Chen, S.-F., Ng, P.-L., Lai, C.-W., Wang, F.-J., Wang, Y.-C., Chen, M.-H., Tung, F.-I., & Liu, T.-Y.
- Affiliations
- Taipei Veterans General Hospital (TW)
- National Yang Ming Chiao Tung University (TW)
- University of Taipei (TW)
- Corresponding author
- Tung, Fu-I
- Liu, Tse-Ying
- Venue
- Journal of Nanobiotechnology
- Published
- 2025-02-12
- Volume
- 23
- Issue
- 1
- Pages
- 105-105
- ISSN
- 1477-3155 (ISSN-L)
- PMC
- PMC11823237
- OpenAlex
- W4407391075
- Cited by
- 11
- References
- 54
- Citations by year
- 2026: 8 · 2025: 3
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Journal of Nanobiotechnology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Department of Health, Taipei City Government (11201-62-004 and 11301-62-048)
- National Science and Technology Council (MOST 111-2221-E-A49-051-MY2, MOST 111-2811-E-A49A-007-MY2, MOST 111-2314-B-038-094)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cerium oxide nanoparticles, bacterial outer membrane vesicles, radiotherapy, triple-negative breast cancer, metastatic breast cancer, abscopal effect, immunogenic cell death, bystander effect, macrophage polarization, systemic antitumor immunity, biomimetic nanomaterials, radiation-induced immunomodulation
- MeSH terms
- Bacterial Outer Membrane, Animals, Antineoplastic Agents, Cerium, Female, Humans, Mice, Inbred BALB C, Cell Line, Tumor, Mice, Nanoparticles, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bacterial membrane-modified cerium oxide nanoboosters enhance systemic antitumor effects of radiotherapy in metastatic triple-negative breast cancer. https://app.cochat.ai/papers/10.1186/s12951-025-03187-3
- The paper
- Chen, S.-F., Ng, P.-L., Lai, C.-W., Wang, F.-J., Wang, Y.-C., Chen, M.-H., Tung, F.-I., & Liu, T.-Y. (2025). Bacterial membrane-modified cerium oxide nanoboosters enhance systemic antitumor effects of radiotherapy in metastatic triple-negative breast cancer. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-025-03187-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.